- DETERMINE the cause of Alzheimer’s disease and other dementias
- DISCOVER markers that allow for the early diagnosis of Alzheimer’s disease and other diseases affecting memory
- DEVELOP safe and affordable therapies that slow or prevent the onset and progression of Alzheimer’s disease and other neurological diseases affecting memory
- DELIVER and champion best care practices for brain health and disease management
- PROMOTE a culture of creativity, community, collaboration, and mentorship
Why are we dedicated to this mission?
All of our brains are at risk. Of the top 10 causes of death in America, Alzheimer’s is the only disease that cannot be prevented, cured, or significantly slowed.
Currently, very few FDA-approved drugs are available to treat the symptoms of Alzheimer’s disease. Alzheimer’s treatments focus on symptom management and, in early stages, slowing disease progression. Options include FDA-approved amyloid-targeting infusions, medications aimed at improving cognitive function and memory, and supportive non-drug approaches including diet, exercise and social activity.
As of 2025, an estimated 7.2 million Americans age 65 and older are living with Alzheimer’s dementia (2025 Alzheimer's Disease Facts and Figures).